Last reviewed · How we verify
NCT07364903: FINC
Effectiveness of Family-Integrated Newborn Care to Improve Outcomes for Preterm and Low-birth-weight Neonates
NA trial testing Family Integrated Newborn Care, an intervention to integrate family in the care targeted their preterm and Low-birth weight neonates in Family Involvement/Empowerment in 1,020 participants. Currently enrolling.
15 June 2026
Quick facts
| Lead sponsor | Laerdal Foundation |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 1,020 |
| Start date | 16 December 2025 |
| Primary completion | 15 June 2026 |
| Estimated completion | 16 June 2026 |
| Sites | 2 locations across Ethiopia |
Drugs / interventions tested
- Family Integrated Newborn Care, an intervention to integrate family in the care targeted their preterm and Low-birth weight neonates
- Standard medical treatment — full drug profile →
Conditions studied
- Family Involvement/Empowerment — all drugs for Family Involvement/Empowerment →
- Family-centered Care — all drugs for Family-centered Care →
- Intensive Care Units, Neonatal — all drugs for Intensive Care Units, Neonatal →
- Family Integrated Newborn Care — all drugs for Family Integrated Newborn Care →
Sponsor
Laerdal Foundation
Who can join
Eligibility, any sex, with Family Involvement/Empowerment or Family-centered Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this quasi-experimental study is to learn if integrating family in newborn care units as a key partner can improve the outcomes of preterm and low-birth-weight neonates. The main question\[s\] that the study aims to answer: • Does the implementation of the FINC intervention impact the neonatal outcomes for preterm and low-birth weight neonates in NCUs in resource-limited settings of Tigray, Northern Ethiopia? Researchers will compare the Length of hospital stay among preterm and low-birth-weight neonates admitted to hospitals included in the intervention groups and compared to the neonates admitted to hospitals in the control group. In the intervention groups, family of preterm and low-birth-weight neonates will be trained, mentored, and integrated into the care targeted to their neonates.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07364903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07364903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Laerdal Foundation
- Last refreshed: 23 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07364903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing